Filing Details
- Accession Number:
- 0001225208-10-020855
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-14 17:55:30
- Reporting Period:
- 2010-09-10
- Filing Date:
- 2010-09-14
- Accepted Time:
- 2010-09-14 17:55:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346102 | E John Celentano | 345 Park Avenue New York NY 10154 | Svp Hr Public Affairs & Philan | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2010-09-10 | 58,333 | $24.74 | 123,674 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-09-10 | 52,297 | $22.14 | 175,971 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-09-10 | 42,500 | $23.14 | 218,471 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-09-10 | 42,200 | $22.73 | 260,671 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-09-10 | 26,250 | $25.45 | 286,921 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2010-09-10 | 25,500 | $27.05 | 261,421 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2010-09-10 | 38,425 | $27.04 | 222,996 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2010-09-10 | 39,050 | $27.04 | 183,946 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2010-09-10 | 46,975 | $27.04 | 136,971 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2010-09-10 | 55,750 | $27.04 | 81,221 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2010-09-10 | 52,297 | $27.04 | 52,297 | $22.14 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2010-09-10 | 42,200 | $27.04 | 42,200 | $22.73 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2010-09-10 | 58,333 | $27.04 | 58,333 | $24.74 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2010-09-10 | 26,250 | $27.05 | 26,250 | $25.45 |
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2010-09-10 | 42,500 | $27.04 | 42,500 | $23.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 52,297 | 2018-03-03 | No | 4 | M | Direct | |
| 0 | 2016-03-06 | No | 4 | M | Direct | |
| 116,667 | 2016-11-30 | No | 4 | M | Direct | |
| 0 | 2015-02-28 | No | 4 | M | Direct | |
| 0 | 2004-03-04 | 2013-03-03 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 3,531 | Indirect | By BMY Savings & Investment Program |
Footnotes
- Shares used to cover cost of exercise price, taxes, and commisions.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- Currently Exercisable.
Billionaire Hedge Funds
